HPC4 and Prostate Cancer, Hereditary, 4: Association Evidence

Gene-Disorder Association · Article

Gene

HPC4

Prostate Cancer, Hereditary, 4

Disorder

First reported 1988

Key publication · disorder The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody.The Journal of biological chemistry · 1988

Manually curated

Association Review

In brief

The association between HPC4 (Prostate Cancer, Hereditary, 4) and Prostate Cancer, Hereditary, 4 is a manually-curated gene–disease association, drawing on a single expert-curated source, which records a susceptibility locus.

Sources 1

Clinical variants 0

Symptoms 0

Compounds 0

Trials 0

Publications 0

At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access

Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access

Prostate Cancer, Hereditary, 4

The disorder

4 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access

Provenance

References & sources

1 reference

Every source and publication cited across this dossier, as one numbered reference list.

Request access